A CRISPR-based detection solution for SARS-CoV-2

Mammoth Biosciences is developing a turnkey workstation to run a CRISPR-based SARS-CoV-2 molecular assay based on automated liquid handling equipment. This high throughput system can perform thousands of tests per day with minimal user interaction. CLIA high complexity laboratories will be able to significantly increase capacity with minimal FTE support to meet increasing demand. Learn more from our recent press release.

*This product has not been evaluated by the Food and Drug Administration and no emergency use authorization has been granted. Mammoth Biosciences is intending to submit for FDA EUA.

  • Fast

    Process samples quickly

    Thousands of samples per day

  • Automated

    Save on labor

    Just one hour of hands on time for an 8 hour period

  • Efficient

    Reduce supply chain burdens

    Novel reagents and fewer automation tips

Learn more about the Hamilton Microlab® CRISPRdetect STAR™ Learn More

Learn more about Agilent’s Bravo BenchCel DB Learn More

Contact Us

    Request more information on the DETECTR BOOST™ SARS CoV-2 Reagent Kit. Simply complete the following form and a representative will be in touch with you.

    Is your lab currently performing molecular COVID-19 testing?*

    How many COVID-19 tests per day does your lab currently perform?*

    How many COVID-19 tests per day is your lab looking to scale to per day?*